A detailed history of Gts Securities LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Gts Securities LLC holds 106,500 shares of AUPH stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
106,500
Previous 95,700 11.29%
Holding current value
$1.03 Million
Previous $546,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.32 - $7.33 $112,267 - $154,684
21,103 Added 65.49%
53,327 $390,000
Q2 2024

Aug 14, 2024

SELL
$4.81 - $5.78 $447,556 - $537,811
-93,047 Reduced 74.28%
32,224 $183,000
Q1 2024

May 15, 2024

BUY
$4.93 - $9.31 $532,050 - $1 Million
107,921 Added 622.02%
125,271 $627,000
Q4 2023

Feb 14, 2024

BUY
$7.13 - $9.49 $123,705 - $164,651
17,350 New
17,350 $155,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.37B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.